{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:40Z","timestamp":1757618980897,"version":"3.44.0"},"reference-count":4,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1136\/ejhpharm-2022-003650","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:21:03Z","timestamp":1671801663000},"page":"84-85","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Capecitabine: guaranteed access in adjuvant treatment of breast cancer"],"prefix":"10.1136","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-7727","authenticated-orcid":false,"given":"Ana Isabel","family":"Cachafeiro Pin","sequence":"first","affiliation":[{"name":"Pharmacy, Hospital Da Mari\u00f1a, Burela, Galicia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0649-2571","authenticated-orcid":false,"given":"Laura","family":"Villaverde Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Pharmacy, Hospital Comarcal de Monforte, Monforte de Lemos, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Alejandra","family":"Saenz Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Pharmacy, Hospital Da Mari\u00f1a, Burela, Galicia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Fern\u00e1ndez Sobrado","sequence":"additional","affiliation":[{"name":"Medical Oncology, University Hospital Lucus Augusti, Lugo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"2025090702141913000_31.1.84.1","unstructured":"AEMPS (Spanish Agency of Medicines and Health Products) . Summary of product characteristics (SmPC) Xelcip 500 mg tablets. CIMA (Medical Online Information Centre), Ministry of Health. Available: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/78583\/FT_78583.html [Accessed 15 Nov 2022]."},{"key":"2025090702141913000_31.1.84.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645"},{"key":"2025090702141913000_31.1.84.3","unstructured":"Royal Decree 1015\/2009, of 19 June, which regulates the availability of medicines in special situations. Official State Gazette (\u201cBOE\u201d in Spanish) No. 174 (20 July 2009). Available: https:\/\/www.boe.es\/buscar\/doc.php?id=BOE-A-2009-12002 [Accessed 15 Nov 2022]."},{"key":"2025090702141913000_31.1.84.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2022-003650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:14:28Z","timestamp":1757236468000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2022-003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":4,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,27]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/ejhpharm-2022-003650"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2022-003650","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}